Vectibix
FDA approves Amgen’s heart failure drug
April 16, 2015Sales and Marketing Amgen, Corlanor, FDA, NICE, Vectibix, heart, ivabradine
Amgen has earned sign-off from the FDA for Corlanor as a treatment for people with worsening heart failure symptoms. Corlanor …
Amgen’s colorectal cancer drug EU approved
April 8, 2015Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa
The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …
Amgen moves into Japanese market with Astellas deal
May 29, 2013Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang
Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …
NICE rejects three bowel cancer drugs
September 5, 2011Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer
NICE says three treatments – Roche’s Avastin, Merck KgAa’s Erbitux and Amgen’s Vectibix – are all not cost effective in …
Amgen plant will boost Boehringer Ingelheim’s US presence
January 21, 2011Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing
Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …
Amgen’s Vectibix fails late stage trial
August 12, 2010Research and Development, Sales and Marketing Amgen, Vectibix, head and neck cancer
Amgen’s potential head and neck cancer treatment Vectibix has failed to meet its primary endpoint of improving overall survival in …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
